Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Global Myasthenia Gravis Treatment Market (2023-2028) by Type, End-User, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Myasthenia Gravis Treatment Market is estimated to be USD 1.33 Bn in 2023 and is expected to reach USD 1.89 Bn by 2028, growing at a CAGR of 7.3%.
Market Dynamics
Drivers
- Growing Geriatric Population Across the Globe
- Increasing Cases of Swollen Eyes Due to Myasthenia Gravis
- Rising Clinical Trials for Treatment
Restraints
- High Cost Associated with the Treatment
Opportunities
- Improving Healthcare Infrastructure
- Upsurge in the Number of Pipeline Studies for Drug Development
Challenges
- Side Effects Associated with Drugs
Market Segmentations
The Global Myasthenia Gravis Treatment Market is segmented based on Type, End-User, and Geography.
- By Type, the market is classified into Medication and Surgery.
- By End-User, the market is classified into Clinics and Hospitals.
- By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.
Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Myasthenia Gravis Treatment Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Myasthenia Gravis Treatment Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Myasthenia Gravis Treatment Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 and impact of economic slowdown & impending recession on the market are also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 154 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $1.33 Billion |
| Forecasted Market Value (USD) by 2028 | $1.89 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global Myasthenia Gravis Treatment Market, By Type
7 Global Myasthenia Gravis Treatment Market, By End-Users
8 Americas' Myasthenia Gravis Treatment Market
9 Europe's Myasthenia Gravis Treatment Market
10 Middle East and Africa's Myasthenia Gravis Treatment Market
11 APAC's Myasthenia Gravis Treatment Market
12 Competitive Landscape
13 Company Profiles
14 Appendix
Companies Mentioned
- AbbVie, Inc.
- Alexion Pharmaceutical, Inc.
- Argenx SE
- Avadel Pharmaceuticals, PLC
- Bausch Health Companies, Inc.
- Catalyst Pharmaceuticals, Inc.
- CSL Behring Ag
- F.Hoffmann-La Roche Ag
- Avadel Pharmaceuticals PLC
- Fresenius Kabi Ag
- GSK PLC
- Grifols SA
- Lupin Pharmaceuticals Pvt. Ltd.
- Mitsubishi Tanabe Pharma Corp.
- Novartis Ag
- Pfizer, Inc.
- Sandoz, Inc.
- Shire PLC
- Sun Pharmaceuticals Industries Ltd.
- Taj Pharmaceuticals Ltd.
- Takeda Pharmaceuticals Co. Ltd.
- Troikaa Pharmaceuticals Ltd.
- Bausch Health Companies, Inc.
- Zydus Cadila Healthcare Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/s4cnz0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
